***Breaking News: Sinovac COVID-19 Vaccine Production Suspended***
The suspension of the Sinovac COVID-19 vaccine has caused a stir in China and around the world. The vaccine, widely promoted by the CCP, has been completely discontinued amid growing concerns over its safety and effectiveness.
On January 10, a document from Beijing Sinovac Zhongwei Biotechnology Company circulated on social media, stating that production of all COVID-19 vaccines has been halted and the company has no products for sale. It has also decided to stop paying employees COVID-19 project performance wages from January 2024.
The suspension of the vaccine comes as Sinovac’s sales have plummeted dramatically in recent years. In 2022, the company reported a 92% drop in annual sales, and the 2023 interim report showed an 88% year-on-year decrease in sales in the first half of the year.
China has also stopped production of many new coronavirus inactivated vaccines and plans to launch new XBB vaccines, but the willingness of the Chinese public to get vaccinated has significantly decreased.
The safety and effectiveness of the Sinovac vaccine have been called into question, with reports of side effects such as measles, leukemia, diabetes, and even sudden deaths. Many individuals have complained about the adverse effects experienced by their relatives after receiving the vaccine.
However, those who have attempted to seek redress for vaccine-related issues have been met with resistance and even persecution by the authorities. Cases of individuals being detained or banned from social media after questioning the vaccine‘s safety have raised further concerns.
In addition, a number of prominent COVID-19 vaccine and virus research experts who supported the CCP have died of illness at relatively young ages, sparking speculation and raising questions about potential repercussions.
The suspension of the Sinovac vaccine and the controversies surrounding its safety have reignited the debate over China’s vaccine policies, leaving many wary of taking COVID-19 vaccines in light of these developments.
As questions and concerns continue to mount, the Chinese public is increasingly apprehensive about the safety and efficacy of vaccines promoted by the CCP, and the future of COVID-19 vaccination in the country remains uncertain.